[GENP] YoY Annual (Unaudited) Result on 31-Dec-2015 [#4]

Stock
[GENP] GENTING PLANTATIONS BERHAD
Announcement Date
22-Feb-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Dec-2015 [#4]
Profit Trend
YoY- -49.7%
Quarter Report
Latest QR
Upcoming QR
GENP's Result
GENP's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 1,902,899 1,804,250 1,480,079 1,374,931 1,642,939 1,384,009 1,233,417 7.49%
PBT 207,736 461,127 448,771 247,429 519,786 300,325 403,838 -10.48%
Tax -60,783 -116,339 -121,280 -70,834 -136,009 -80,462 -81,965 -4.85%
NP 146,953 344,788 327,491 176,595 383,777 219,863 321,873 -12.24%
-
NP to SH 164,898 337,710 338,213 189,749 377,245 227,797 327,063 -10.78%
-
Tax Rate 29.26% 25.23% 27.02% 28.63% 26.17% 26.79% 20.30% -
Total Cost 1,755,946 1,459,462 1,152,588 1,198,336 1,259,162 1,164,146 911,544 11.54%
-
Net Worth 4,114,892 4,287,016 4,256,038 4,176,182 3,869,571 3,429,854 3,422,399 3.11%
Dividend
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Div 104,479 206,411 165,819 42,614 76,473 362,335 94,855 1.62%
Div Payout % 63.36% 61.12% 49.03% 22.46% 20.27% 159.06% 29.00% -
Equity
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Net Worth 4,114,892 4,287,016 4,256,038 4,176,182 3,869,571 3,429,854 3,422,399 3.11%
NOSH 805,649 803,399 789,617 774,801 764,737 758,817 758,846 1.00%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 7.72% 19.11% 22.13% 12.84% 23.36% 15.89% 26.10% -
ROE 4.01% 7.88% 7.95% 4.54% 9.75% 6.64% 9.56% -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 236.77 227.27 187.44 177.46 214.84 182.39 162.54 6.46%
EPS 20.50 42.13 42.84 24.49 49.33 30.02 43.10 -11.64%
DPS 13.00 26.00 21.00 5.50 10.00 47.75 12.50 0.65%
NAPS 5.12 5.40 5.39 5.39 5.06 4.52 4.51 2.13%
Adjusted Per Share Value based on latest NOSH - 772,418
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 212.06 201.06 164.94 153.22 183.09 154.23 137.45 7.49%
EPS 18.38 37.63 37.69 21.15 42.04 25.39 36.45 -10.77%
DPS 11.64 23.00 18.48 4.75 8.52 40.38 10.57 1.61%
NAPS 4.5856 4.7774 4.7429 4.6539 4.3122 3.8222 3.8139 3.11%
Price Multiplier on Financial Quarter End Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 -
Price 9.86 10.50 10.80 10.60 10.00 11.04 9.00 -
P/RPS 4.16 4.62 5.76 5.97 4.65 6.05 5.54 -4.66%
P/EPS 48.06 24.68 25.21 43.28 20.27 36.78 20.88 14.89%
EY 2.08 4.05 3.97 2.31 4.93 2.72 4.79 -12.97%
DY 1.32 2.48 1.94 0.52 1.00 4.33 1.39 -0.85%
P/NAPS 1.93 1.94 2.00 1.97 1.98 2.44 2.00 -0.59%
Price Multiplier on Announcement Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 26/02/19 26/02/18 22/02/17 22/02/16 25/02/15 26/02/14 27/02/13 -
Price 10.62 9.80 11.08 11.00 10.22 10.50 8.47 -
P/RPS 4.49 4.31 5.91 6.20 4.76 5.76 5.21 -2.44%
P/EPS 51.76 23.04 25.87 44.92 20.72 34.98 19.65 17.50%
EY 1.93 4.34 3.87 2.23 4.83 2.86 5.09 -14.91%
DY 1.22 2.65 1.90 0.50 0.98 4.55 1.48 -3.16%
P/NAPS 2.07 1.81 2.06 2.04 2.02 2.32 1.88 1.61%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment